Predictive factors for response to endocrine therapy in patients with recurrent Breast Cancer
โ Scribed by Hiroshi Sonoo; Junichi Kurebayashi
- Publisher
- Springer Japan
- Year
- 2000
- Tongue
- English
- Weight
- 516 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1340-6868
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
This review presents our experience with the use of estrogen receptors (ER) and progesterone receptors (PgR) in the prediction of response to endocrine therapy in stage IV breast cancer. Presence of ER (>3 fmoUmg cytosol protein) significantly predicted response to the antiestrogen tamoxifen and to
Background and Objectives: Chest wall recurrence occurs in 5-20% of breast cancer patients. Until recently, the only treatments available were surgical resection or radiotherapy. Photodynamic therapy (PDT) is a new modality that uses a photosensitizer and light to destroy tumor cells selectively. We